Philadelphia Trust CO Biogen Inc. Transaction History

Philadelphia Trust CO

$1.29 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $588,909 - $756,835	-2,630 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $10.8 Million - $17.4 Million	-41,867 Reduced 94.09%	2,630 $911,000
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $485 - $569	2 Added 0.0%	44,497 $12.4 Million
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $43,708 - $65,791	-185 Reduced 0.41%	44,495 $10.9 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $282,774 - $326,498	1,068 Added 2.45%	44,680 $12.7 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $2.38 Million - $3.15 Million	-9,194 Reduced 17.41%	43,612 $11.7 Million
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $627,495 - $795,987	-2,334 Reduced 4.23%	52,806 $16.7 Million
Q4 2019 Feb 10, 2020	SELL	$220.06 - $304.07 $4.1 Million - $5.67 Million	-18,642 Reduced 25.27%	55,140 $16.4 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $997,614 - $1.12 Million	-4,588 Reduced 5.85%	73,782 $17.2 Million
Q2 2019 Aug 08, 2019	SELL	$219.29 - $241.72 $667,518 - $735,795	-3,044 Reduced 3.74%	78,370 $18.3 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $1.44 Million - $2.25 Million	6,634 Added 8.87%	81,414 $19.2 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $912,087 - $1.16 Million	-3,275 Reduced 4.2%	74,780 $22.5 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $1.21 Million - $1.58 Million	-4,128 Reduced 5.02%	78,055 $27.6 Million
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $3.06 Million - $3.65 Million	-11,879 Reduced 12.63%	82,183 $23.9 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $1.56 Million - $2.21 Million	-6,001 Reduced 6.0%	94,062 $25.8 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $161,511 - $180,904	-525 Reduced 0.52%	100,063 $31.9 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $28.3 Million - $33.2 Million	100,588	100,588 $31.5 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.

Account